The Government Accountability Office (GAO) recently issued a report on consumer access to hearing loss treatment following the market availability of over-the-counter (OTC) hearing aids in October 2022. GAO reviewed literature and agency documents and interviewed Food and Drug Administration (FDA) and Federal Trade Commission (FTC) officials, and a selection of eight stakeholder groups representing consumers, audiologists, hearing professionals, and the hearing aid industry.
FDA officials and six of the eight stakeholder groups GAO interviewed said it was too early after implementation of the final rule to have data on its effects. In addition, research and external stakeholder groups reported that barriers to accessing hearing loss treatment continue to exist, even with the availability of OTC hearing aids. These barriers include consumer preferences, professional concerns, difficulty assessing hearing loss, and affordability.
Recent Posts
Mississippi and Missouri Go Live in ASLP Compact
The Audiology & Speech-Language Pathology Interstate Compact (ASLP-IC) continues to expand, with Mississippi officially going live on November 9, and Missouri following on November 16. With…
Senators Merkley and Gillibrand Introduce Professional Student Degree Act
Senators Jeff Merkley (D-OR) and Kirsten Gillibrand (D-NY) have introduced the Professional Student Degree Act in the Senate, companion legislation to H.R. 6718, introduced in the…
CMS Offers States an Optional Pause on Medicaid Work Requirement Enforcement
On November 13, 2026, CMS announced that states may protect otherwise eligible Medicaid applicants and beneficiaries from work-requirement-related coverage denials through June 30, 2027. The…



